Side effects of prostate cancer therapies and potential management
Open Access
- 22 August 2024
- journal article
- review article
- Published by Journal of Biological Methods in Journal of Biological Methods
- Vol. 11 (3) , e99010018
Abstract
Prostate cancer (PCa) remains a significant health challenge, necessitating diverse therapeutic interventions to manage the disease effectively. While these treatments offer promising outcomes, they are often accompanied by a range of side effects that can impact patient quality of life and treatment compliance. This review provides an overview of the common side effects associated with various PCa therapies, including prostatectomy, radiation therapy, thermal therapy, hormone therapy, chemotherapy, and targeted drug therapy, among others. We summarized and discussed the reported side effects encompassing ureteral problems, sexual issues, gastrointestinal symptoms, fatigue, anemia, thrombocytopenia, hematologic abnormalities, nausea, vomiting, and liver enzyme elevation. Specific managements, such as personalized treatment plans, proactive symptom monitoring, supportive care interventions, and hematological assessments, are crucial in mitigating these side effects and optimizing treatment outcomes. By prioritizing patient-centered care and tailored interventions, health-care providers can enhance treatment efficacy and improve the overall well-being of individuals undergoing PCa therapies.Keywords
This publication has 103 references indexed in Scilit:
- Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinomaCancer, 1996
- Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: The patient's perspectiveUrology, 1996
- The incidence and management of rectal injury associated with radical prostatectomy in a community based urology practice.1995
- Effects of the luteinizing hormone-releasing hormone agonist leuprolide on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia.1995
- Incontinence and vesical neck strictures following radical retropubic prostatectomyUrology, 1995
- One hundred consecutive laparoscopic pelvic lymph node dissections: Comparing complications of the first 50 cases to the second 50 casesUrology, 1994
- Early complications of combined pelvic lymphadenectomy and radical prostatectomy versus lymphadenectomy aloneThe Prostate, 1986
- Perioperative complications of pelvic lymphadenectomy and radical retropubic prostatectomy for stages C and D1 prostate cancerUrology, 1984
- Pelvic Lymphadenectomy in the Management of Carcinoma of the ProstateJournal of Urology, 1980
- Pre-Estrogen Breast Irradiation for Patients with Carcinoma of the Prostate: A Critical ReviewJournal of Urology, 1979